China is starting clinical trials for a COVID-19 vaccine that can be inhaled! Yes, China’s CanSino Biologics started clinical trials for a COVID-19 vaccine administered through inhalation at the end of April 2021. Per the company’s Chief Executive Xuefeng Yu, such a vaccine would be more effective than those injected given that the coronavirus enters the human body through the airways.
CanSinoBIO’s single-dose injected COVID vaccine has been approved for use in several countries including China, Pakistan, Mexico and Hungary. The company said interim data from phase three clinical trials overseas showed its vaccine was 68.83% effective at preventing symptomatic COVID-19 disease two weeks after one injection, while the rate fell to 65.28% after four weeks. In comparison, updated data showed the Pfizer-BioNTech shot was 91% effective at preventing infection, while Moderna said its vaccine was more than 90% effective six months after the second shot.
Lots of exciting research being done, imagine, a vaccine you inhale versus getting jabbed! We do a lot of postings on research and hope you find it interesting and helpful as without our researchers we would have no vaccine at all today! Stay well, mask up indoors and stay tuned!